Document Detail


Some qualitative differences of hCG in serum from early and late pregnancies and trophoblastic diseases.
MedLine Citation:
PMID:  2827418     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Twenty-four sera were obtained from women in the first and third trimester of pregnancy, women with gestational choriocarcinoma, and men with testicular hCG-producing tumours. The hCG-activity was measured by an in vivo bioassay (B) based upon the increase in mouse uterine weight. The sera were also analysed by three immunoassays (I), one for hCG, one for alpha-hCG subunits, and one for beta-subunits. All sera were also subjected to electrophoresis in 0.17% agarose suspension in 0.075 mol/l sodium veronal buffer at pH 8.6, and median charge, expressed as median mobility, was estimated for hCG. The metabolic clearance rate (MCR) of hCG in serum in early and late pregnancy and from one patient with choriocarcinoma was measured in mice. The B/I ratio was lower and the forms of hCG were less negatively charged in late pregnancy compared with early pregnancy. The lower B/I ratio might be due to the higher MCR of hCG in the test animal in the in vivo bioassay. The B/I ratio in choriocarcinoma was higher than in early pregnancy. However, the median charge of hCG was almost identical in these two groups. The most negatively charged forms of hCG were found in the men with testicular tumours. The four groups: early pregnancy, late pregnancy, gestational choriocarcinoma, and testicular tumours could be differentiated by measuring the median charge and the B/I ratio of hCG in serum. The production, later in pregnancy, of forms of hCG which disappear faster from the circulation might partially explain the lower hCG concentration in serum at this stage of gestation.
Authors:
L Wide; B Hobson
Related Documents :
16311298 - Defining the rise of serum hcg in viable pregnancies achieved through use of ivf.
7376988 - Inhibition of pg biosynthesis as the maintenance mechanism of pregnancy of hcg.
14764788 - Trophoblast production of a weakly bioactive human chorionic gonadotropin in trisomy 21...
12916678 - Low maternal serum concentrations of human chorionic gonadotropin as part of the triple...
10328868 - Administration of recombinant human stem cell factor (rhscf) and granulocyte-colony sti...
9440798 - Immunohistochemical study of microtubule-associated protein 5 (map5) expression in the ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Acta endocrinologica     Volume:  116     ISSN:  0001-5598     ISO Abbreviation:  Acta Endocrinol.     Publication Date:  1987 Dec 
Date Detail:
Created Date:  1988-02-08     Completed Date:  1988-02-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370312     Medline TA:  Acta Endocrinol (Copenh)     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  465-72     Citation Subset:  IM    
Affiliation:
Department of Clinical Chemistry, University Hospital, Uppsala, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Biological Assay
Choriocarcinoma / blood
Chorionic Gonadotropin / blood*
Electrophoresis, Agar Gel
Female
Humans
Immunoassay
Male
Mice
Mice, Inbred Strains
Pregnancy / blood*
Testicular Neoplasms / blood
Trophoblastic Neoplasms / blood*
Uterine Neoplasms / blood*
Chemical
Reg. No./Substance:
0/Chorionic Gonadotropin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Conclusive diagnosis of hepatic and pancreatic malignancies by fine needle aspiration.
Next Document:  Detection of heterozygous carriers for 21-hydroxylase deficiency by plasma 21-deoxycortisol measurem...